Diabetic Retinopathy After Two Years of Intensified Insulin Treatment: Follow-up of The Kroc Collaborative Study

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 1, 1988, Pages 37-41

 

^a Kroc Collaborative Study Group ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

DIABETIC RETINOPATHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BLOOD GLUCOSE; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC RETINOPATHY; EXUDATES AND TRANSUDATES; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; INJECTIONS, SUBCUTANEOUS; INSULIN; RANDOM ALLOCATION; RETINAL VESSELS; SUPPORT, NON-U.S. GOV'T;

EID: 2642668188     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410010045032     Document Type: Article

References (17)

1. Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1985;311:365-372.
2. Davis MD, Hubbard L, Trautman J, et al.: Kroc Collaborative Study Group: Studies of retinopathy: Methodology for assessment and classification with fundus photographs. Diabetes 1985;34(suppl 3):42-49.
3. Lauritzen T, Frost-Larsen K, Larsen HW, et al.: The Steno Study Group: Effect of one year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes. Lancet 1983;1:200-204.
4. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al., and the Aker Diabetes Group: Rapid tightening of blood glucose control leads to transient deterioration in retinopathy in insulindependent diabetes mellitus—the Oslo Study. Br Med J 1985;290:811-815.
5. Winer BJ: Statistical Principles in Experimental Design. New York, McGraw-Hill International Book Co, 1971, pp 514-603.
6. Kohner EM, McLeod D, Marshall J: Diabetic eye disease, in Keen H, Jarrett RJ (eds): Complications of Diabetes, ed 2. Baltimore, Edward Arnold Publishers Ltd, 1982, pp 57-59.
7. Lauritzen T, Frost-Larsen K, Larsen H-W, et al.: The Steno Study Group: Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985;34(suppl 3):74-79.
8. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al.: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, and neuropathy: The Oslo Study. Br Med J 1986;293:1195-1199.
9. Klein BEK, Davis MD, Segal P, et al.: Diabetic retinopathy assessment of severity and progression. Ophthalmology 1984;91:10-17.
10. Puklin JE, Tamborlane WV, Felig P, et al.: Influence of long-term insulin infusion pump treatment of type 1 diabetes on diabetic retinopathy. Ophthalmology 1982;89:735-747.
11. Lawson PM, Champion MC, Canny CLB, et al.: Continuous subcutaneous insulin infusion does not prevent progression of proliferative and preproliferative retinopathy. Br J Ophthalmol 1982;66:762-766.
12. Van Ballegooie E, Hooyman JMM, Timmerman Z, et al.: Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 1984;7:236-242.
13. Daneman D, Drash AL, Lobes LA, et al.: Progressive retinopathy with improved control in diabetic dwarfism (Mauriac’s syndrome). Diabetes Care 1981;4:360-365.
14. Testa MA, Puklin JE, Sherwin RS, et al.: Clinical predictors of retinopathy and its progression in patients with type 1 diabetes during CSII or conventional insulin treatment. Diabetes 1985; 34(suppl 3):61-68.
15. Keen H: Normoglycaemic re-entry and diabetic complications. Diabetic Med 1984;1:85-87.
16. Brinchmann-Hansen O, Dalh-Jorgensen K, Hanssen KF, et al., and the Oslo Diabetes Study Group: Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 1985;100:644-653.
17. The DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-545.